Impel Pharmaceuticals Inc.
- UEI
- VGX8L65CX5A3
- CAGE
- 55Y39
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Website
- impelpharma.com
- Founded
- 2008
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $11,105 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Acorda Therapeutics, Inc. | — | 325412 Pharmaceutical Preparation Manufacturing |
| U.s. Division | Rockville, MD | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| Amneal Pharmaceuticals Of New York, LLC | Medford, NY | 325412 Pharmaceutical Preparation Manufacturing |
| Federal | Parsippany-Troy Hills, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Olfax Medical | Asheville, NC | — |
About the company
Impel Pharmaceuticals Inc., doing business as Impel, is a for-profit manufacturer specializing in precision olfactory delivery nasal devices for central nervous system diseases. The company has been registered to receive awards from the U.S. federal government since August 2008. Impel primarily provides pharmaceutical products to the federal government through contract awards, with a focus on its acute migraine medication TRUDHESA (dihydroergotamine mesylate) nasal spray. As a manufacturer of goods, Impel's federal contracting activities center on supplying its innovative nasal spray treatments to support veterans' healthcare needs.
Impel's recent federal contract awards have exclusively involved supplying TRUDHESA nasal spray to various Veterans Integrated Service Networks (VISNs) within the Department of Veterans Affairs (VA). The company has received multiple firm fixed price delivery orders from VISN 9 and VISN 12, ranging in value from approximately $3,600 to $3,800 each. These orders support the VA's provision of acute migraine treatment to veterans in the Pacific Northwest region. The delivery orders have been issued against Impel's Federal Supply Schedule contract, with no set-aside designations. By fulfilling these orders from its Seattle, Washington facility, Impel aims to expand timely access to its migraine medication for veterans through the VA's integrated healthcare networks.
Impel Pharmaceuticals Inc. holds two federal contract Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs. The primary IDV is a multiple-award Federal Supply Schedule contract (ID: 36F79722D0182) awarded by the VA Veterans Health Administration, with a ceiling value of $5.2 million and an ultimate completion date of August 14, 2027. This contract provides access to Impel's pharmaceutical products and services, specifically its TRUDHESA nasal spray, to support VA healthcare programs. The second IDV (ID: 36F79722D001E) was an interim agreement under the same FSS Schedule 65 I B for drugs, pharmaceuticals, and hematology-related products. This interim agreement had a much smaller ceiling value of $25,000 and expired on August 14, 2022. Both IDVs were awarded without set-aside designations and enable the VA to place delivery orders for Impel's products through its various regional healthcare networks.
Quick answers
Is Impel Pharmaceuticals Inc. registered in SAM.gov?
Impel Pharmaceuticals Inc.'s SAM.gov registration expired on August 20, 2024.
How much has Impel Pharmaceuticals Inc. received in federal contracts?
Federal contracts obligated $11,105 to Impel Pharmaceuticals Inc. in fiscal years 2023 through 2027.
What is Impel Pharmaceuticals Inc.'s most recent federal award?
Impel Pharmaceuticals Inc.'s most recent federal contract award is Trudhesa nasal spray (36C25224F0185), from Veterans Integrated Service Network 12 (VHA), on June 10, 2024.
On GovTribe
See Impel Pharmaceuticals Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors